New DNA test aims to predict cancer return after transplant

NCT ID NCT02872662

First seen Apr 24, 2026 · Last updated May 14, 2026 · Updated 4 times

Summary

This study looked at 308 patients with MDS (a bone marrow disorder) who had a stem cell transplant. Researchers tracked unique genetic mutations in the patients' blood and bone marrow after transplant to see if they could detect the cancer coming back earlier than standard tests. The goal was to find the level of mutation signals that predict a full relapse, helping doctors intervene sooner.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MDS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Department of Hematology and Coagulation, Sahlgrenska University hospital

    Gothenburg, 413 45, Sweden

  • Department of Hematology, Aarhus University Hospital

    Aarhus, 8000, Denmark

  • Department of Hematology, Akademiska University Hospital

    Uppsala, 751 85, Sweden

  • Department of Hematology, Karolinska University Hospital

    Stockholm, Sweden

  • Department of Hematology, Lund University Hospital

    Lund, 221 85, Sweden

  • Department of Hematology, Rigshospitalet Univsersity Hospital

    Copenhagen, Denmark

  • Department of Hematology, Rikshospitalet University Hospital

    Oslo, 0027, Norway

  • Department of Medcine, Haukeland University Hospital

    Bergen, Norway

Conditions

Explore the condition pages connected to this study.